A partner in the litigation department of Paul Weiss Rifkind Wharton & Garrison, Nicholas Groombridge focuses exclusively on intellectual property litigation matters. Over the past 25 years, he has been extensively involved in all aspects of patent litigation, including trials (both bench and jury). He has been lead counsel in many patent infringement actions in federal district courts, and has successfully argued many cases in the Court of Appeals for the Federal Circuit.
Nicholas has litigated patents in a wide variety of technical areas. In the area of pharmaceuticals and biotechnology, he has handled many litigation and other matters involving assays, biologics, bioinformatics, diagnostics, drugs (both prescription and over-the-counter), drug delivery systems, and research tools. His patent litigation experience also extends to a wide range of other technologies, including medical devices, consumer electronics, software, alternative energy and financial services.
Nicholas is a frequent speaker on developments in patent law, particularly issues relating to the life sciences field. He co-teaches a course on patent litigation New York University School of Law. He has been quoted on intellectual property law issues in leading business publications, including the Wall Street Journal, Fortune and the Financial Times, as well as trade publications such as Scrip and the Pink Sheet.
Nicholas has received many professional accolades. Chambers noted that "[h]e has an excellent ability to understand specific legal issues and translate them to the client in a digestible, understandable and compelling way." He also received top rankings in the national, local, and life sciences categories in Managing Intellectual Property magazine 2017.
He was named as "Litigation Trailblazer" by the National Law Journal, and is one of the Lawdragon 500 Leading Litigators in the US. He is also active in several professional societies including the Federal Circuit Bar Association, in which he serves as past president.